Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer

J Urol. 2022 Feb;207(2):262-264. doi: 10.1097/JU.0000000000002341. Epub 2021 Nov 15.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Male
  • Mass Screening / standards
  • Medical Oncology / standards
  • Neoplasm Staging
  • Patient Selection
  • Practice Guidelines as Topic
  • Prostate / pathology
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy*
  • Risk Assessment
  • Urology / standards
  • Watchful Waiting / standards*